Cargando…
Senescence in the Development and Response to Cancer with Immunotherapy: A Double-Edged Sword
Cellular senescence was first described as a physiological tumor cell suppressor mechanism that leads to cell growth arrest with production of the senescence-associated secretory phenotype known as SASP. The main role of SASP in physiological conditions is to attract immune cells to clear senescent...
Autores principales: | Battram, Anthony M., Bachiller, Mireia, Martín-Antonio, Beatriz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352478/ https://www.ncbi.nlm.nih.gov/pubmed/32570952 http://dx.doi.org/10.3390/ijms21124346 |
Ejemplares similares
-
Natural Killer Cells in Immunotherapy: Are We Nearly There?
por: Bachiller, Mireia, et al.
Publicado: (2020) -
HDAC inhibitors and immunotherapy; a double edged sword?
por: Kroesen, Michiel, et al.
Publicado: (2014) -
Cellular senescence: a double-edged sword in cancer therapy
por: Xiao, Shuai, et al.
Publicado: (2023) -
GM-CSF: A Double-Edged Sword in Cancer Immunotherapy
por: Kumar, Anil, et al.
Publicado: (2022) -
Immunotherapy for Management of Thymic Epithelial Tumors: A Double-Edged Sword
por: Ballman, Madison, et al.
Publicado: (2022)